Figure 1.
Kaplan-Meier curves of disease-specific survival for high-grade serous (HGSC) and endometrioid (EC) carcinomas, according to hormone receptor status. The data were left truncated to avoid potential survival bias from the inclusion of patients (<10%) enrolled >1 year after diagnosis, and right censored at 10 years. P-values correspond to log-rank tests of the equality of survivor functions across hormone receptor expression levels, stratified by study site.
